Biomarkers for Therapy Response in Drug-resistant Tuberculosis

NCT02597621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 192

Last updated 2024-04-11

No results posted yet for this study

Summary

Multi-center, observational, prospective cohort study including patients with multidrug-resistant tuberculosis at different sites in Germany.

The aim the study is the identification of biomarkers for therapy response.

Conditions

  • Tuberculosis, Multidrug-resistant

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Research Center Borstel

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2020-12-31
Completion
2021-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597621 on ClinicalTrials.gov